Physician profile
David Elkins
NPI 1235137571
$7,027.99
in general payments reported to CMS, 2019-2025
43 companies · $1,546 in 2025
The $1,546 reported for 2025 was more than what 87% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,459 · 2022: $1,432 · 2023: $1,341 · 2024: $1,251 · 2025: $1,546.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,137.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $688.46 | 2021-2025 | Xtandi |
| Sumitomo Pharma America, INC. | $620.71 | 2023-2025 | Gemtesa, Orgovyx |
| Procept Biorobotics Corporation | $608.58 | 2024-2025 | Aquabeam System |
| Abbvie INC. | $390.22 | 2021-2025 | |
| Janssen Biotech, INC. | $366.46 | 2021-2025 | Erleada, Balversa, Akeega |
| Endo Pharmaceuticals INC. | $318.95 | 2021-2023 | Aveed, Xiaflex |
| Pfizer INC. | $317.17 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $291.78 | 2021-2023 | |
| Progenics Pharmaceuticals, INC. | $286.13 | 2023-2025 | Pylarify |
| Antares Pharma, INC. | $282.46 | 2021-2023 | Xyosted, Nocdurna, Tlando |
| 180 Medical, INC. | $215.67 | 2022-2025 | Gentlecath Glide, Gentlecath |
| Teleflex LLC | $213.94 | 2024-2025 | Urolift, Rusch |
| Tolmar Pharmaceuticals, INC. | $173.99 | 2021-2022 | |
| Myovant Sciences INC. | $168.79 | 2021-2022 | |
| Medtronic, INC. | $157.90 | 2021-2024 | Interstim |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo USA, INC. | $152.36 | 2024-2025 | Xiaflex, Aveed |
| Astrazeneca Pharmaceuticals Lp | $148.78 | 2021-2023 | Lynparza |
| Myriad Genetic Laboratories, INC. | $135.78 | 2021-2025 | Prolaris |
| Convatec INC. | $135.40 | 2021-2025 | |
| Genzyme Corporation | $131.37 | 2022-2023 | |
| Urogen Pharma, INC. | $122.01 | 2023-2025 | Jelmyto |
| Accord Healthcare, INC. | $114.52 | 2022-2023 | |
| Urovant Sciences INC | $112.46 | 2021-2022 | |
| C. R. Bard, INC. & Subsidiaries | $110.09 | 2025 | |
| Sun Pharmaceutical Industries INC. | $99.61 | 2021-2023 | Yonsa |
| Clarus Therapeutics INC. | $84.67 | 2021 | |
| Boston Scientific Corporation | $68.95 | 2021-2023 | Rezum Generator |
| Merck Sharp & Dohme LLC | $59.00 | 2021-2024 | Keytruda |
| Verity Pharmaceuticals INC. | $58.82 | 2025 | Tlando |
| Tolmar, INC. | $56.93 | 2023-2025 | Jatenzo, Eligard |
| Blue Earth Diagnostics | $50.44 | 2021 | |
| Laborie Medical Technologies Corp. | $40.82 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Calyxo, INC. | $39.68 | 2024-2025 | Cvac Aspiration System |
| Coloplast Corp | $33.72 | 2021-2025 | |
| Rochester Medical Corporation | $27.38 | 2024 | Bard Urinary Drainage Bag |
| Dentsply Ih INC. | $24.27 | 2022 | |
| Novartis Pharmaceuticals Corporation | $21.93 | 2023 | |
| Abc Home Medical Supply, INC. | $19.95 | 2024 | |
| Paratek Pharmaceuticals, INC. | $17.23 | 2023 | Nuzyra |
| Foundation Medicine, INC. | $16.40 | 2023 | |
| Alnylam Pharmaceuticals INC. | $16.02 | 2023 | Oxlumo |
| Halozyme INC | $15.03 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $13.16 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Elkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.